L3VLUP
ProSign in

ALVO in the 13F filings

Alvotech · CUSIP L01800108

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Quarter end
30 Jun 2026
the date the book describes
Filed
2 Sep 2026
latest of these filings; the earliest 13 Aug 2026
Managers listing it
10
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q1 2026 and Q2 2026; 2 listed it in both
Shares listed
10,850,485
combined, among listed positions
Reported value
$40m
combined, at the quarter end

Among the 91 comparable managers: 9 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +6,859,319.

Managers listing ALVO in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

10 of 10 holders

ActionFiling
Millennium Management LLC4,263,644$16munder 0.1%Added+2,141,04814 Aug 2026 (the filing on sec.gov)
Farallon Capital Management LLC2,859,675$11munder 0.1%Added+2,660,00014 Aug 2026 (the filing on sec.gov)
Citadel Advisors LLC1,728,002$6.4munder 0.1%Newnew2 Sep 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc1,418,392$5.2munder 0.1%Added+21,28514 Aug 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP238,107$879kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Oaktree Capital Management LP97,982$362kunder 0.1%Trimmed-142,05614 Aug 2026 (the filing on sec.gov)
Invesco Ltd90,477$334kunder 0.1%Added+12,03014 Aug 2026 (the filing on sec.gov)
Marshall Wace LLP71,788$265kunder 0.1%Newnew13 Aug 2026 (the filing on sec.gov)
Tudor Investment Corp44,465$164kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Jane Street Group LLC37,953$140kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (5)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

011222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
ALVO by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20222$56mn.a.n.a.
Q3 20222$46mn.a.n.a.
Q4 20222$68mn.a.n.a.
Q1 20232$107mn.a.n.a.
Q2 20232$56mn.a.n.a.
Q3 20231$46mn.a.n.a.
Q4 20231$63m10
Q1 20241$35m01
Q2 20241$31m01
Q3 20242$33m10
Q4 20242$28m01
Q1 20252$20m01
Q2 20252$16m01
Q3 20252$14m00
Q4 20252$3.0m45
Q1 20262$1.0m44
Q2 20262$11m93

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

ALVO and GILD →ALVO and AMGN →ALVO and ARGX →Choose a stock to compare with ALVO →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own ALVO, latest filings →Back to the 13F Explorer →